Breaking News Instant updates and real-time market news.

ABT

Abbott

$68.79

0.79 (1.16%)

08:35
11/27/18
11/27
08:35
11/27/18
08:35

Abbott reiterated as a top large-cap pick at JPMorgan

JPMorgan analyst Robbie Marcus reiterates Abbott Laboratories as a top large-cap pick following a headquarter visit. With 2019 Street earnings estimates of $3.20 reflecting "just" 11% growth, the analyst sees "multiple pathways to upside" on both the top and bottom lines next year. He come away from the visit "even more bullish on the multi-year growth story for Alinity." Marcus keeps an Overweight rating on Abbott with an $81 price target.

  • 30

    Nov

ABT Abbott
$68.79

0.79 (1.16%)

10/18/18
LEER
10/18/18
NO CHANGE
Target $75
LEER
Market Perform
Abbott sales growth momentum poised to continue, says Leerink
Looking into 2019, Leerink analyst Danielle Antalffy sees a number of potential drivers of an above-market growth outlook, including ramping adoption in Freestyle Libre with rollout of Libre 2 in EU and anticipated U.S. launch upon FDA approval, continued turnaround in Nutritionals, and a likely acceleration of MitraClip sales following very strong COAPT data in functional mitral regurgitation, assuming some volume pull-through ahead of an FDA/reimbursement approval. The analyst reiterates a Market Perform rating and $75 price target on the shares.
10/23/18
JPMS
10/23/18
NO CHANGE
Target $81
JPMS
Overweight
Abbott remains a top large-cap pick at JPMorgan
Following a deep dive into the company's Alinity and the Diagnostics opportunity, JPMorgan analyst Robbie Marcus says Abbott Laboratories remains a top large-cap pick due to its "top-tier growth outlook and multiple 2019 catalysts." In the large-cap MedTech universe, Abbott's organic growth profile for 2019 at ~7% puts it near the top end of its peer group, Marcus tells investors in a research note. He believes Abbott has a "clear pathway" to post double-digit earnings growth through 2022. Heading into 2019, Abbott's Diagnostics growth is poised to accelerate on the ongoing roll-out of Alinity in Europe, the mid-year launch of Alinity in the U.S., the recovery of the Alere Rapid Diagnostics, Marcus contends. He keeps an Overweight rating on the shares with an $81 price target.
10/25/18
PIPR
10/25/18
NO CHANGE
Target $25
PIPR
Overweight
Nuvectra recent selloff brings 'excellent entry point,' says Piper Jaffray
Piper Jaffray analyst Matt O'Brien believes the recent Q3 results of neuromodulation incumbents, Boston Scientific (BSX) and Abbott (ABT), "reinforce the dynamic characteristics" of the spinal cord stimulation marketplace. Nuvectra's (NVTR) Algovita is likely one of the beneficiaries and could post upside in the quarter, O'Brien tells investors in a research note. The analyst says Nuvectra continues to be his top-microcap pick with a "reasonable valuation." Further, the recent softness in the shares "provides an excellent entry point for a name that is still in the early innings of gaining SCS share." He keeps an Overweight rating on Nuvectra with a $25 price target.
11/07/18
JEFF
11/07/18
NO CHANGE
Target $148
JEFF
Buy
DexCom price target raised to $148 from $125 at Jefferies
Jefferies analyst Raj Denhoy raised his price target for DexCom (DXCM) to $148 saying the company posted "strong" Q3 results. Improving market access from pharmacy benefit is driving patient adds and helping blunt any advantage for Abbott's (ABT) Libre, says the analyst. He keeps a Buy rating on DexCom citing strong G6 adoption, new patients accelerating and still underpenetrated markets.

TODAY'S FREE FLY STORIES

BBCP

Concrete Pumping

$4.33

0.195 (4.72%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Earnings
Concrete Pumping reports Q3 EPS 5c, consensus 7c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

MRVL

Marvell

$25.42

-0.43 (-1.66%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Hot Stocks
Marvell's Gaynor sells 35,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAST

Eastside Distilling

$4.99

-0.01 (-0.20%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Hot Stocks
Eastside Distilling acquires Azunia Tequila in all-stock transaction »

Eastside Distilling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNG

Cheniere Energy

$65.71

0.21 (0.32%)

, EOG

EOG Resources

$85.61

6.24 (7.86%)

16:06
09/16/19
09/16
16:06
09/16/19
16:06
Hot Stocks
Cheniere Energy, EOG Resources announce gas supply agreements »

Cheniere Energy (LNG)…

LNG

Cheniere Energy

$65.71

0.21 (0.32%)

EOG

EOG Resources

$85.61

6.24 (7.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UFPI

Universal Forest

$40.47

-0.66 (-1.60%)

16:06
09/16/19
09/16
16:06
09/16/19
16:06
Hot Stocks
Universal Forest acquires Pallet USA »

Universal Forest Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BJ

BJ's Wholesale

$26.81

-0.64 (-2.33%)

16:05
09/16/19
09/16
16:05
09/16/19
16:05
Hot Stocks
BJ's Wholesale names Lee Delaney president »

BJ's Wholesale Club…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

PSTV

Plus Therapeutics

$9.50

-0.06 (-0.63%)

16:05
09/16/19
09/16
16:05
09/16/19
16:05
Syndicate
Breaking Syndicate news story on Plus Therapeutics »

Plus Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$1.10

0.065 (6.31%)

16:00
09/16/19
09/16
16:00
09/16/19
16:00
Hot Stocks
Breaking Hot Stocks news story on Aclaris Therapeutics »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETN

Eaton

$86.32

-1.15 (-1.31%)

15:54
09/16/19
09/16
15:54
09/16/19
15:54
Hot Stocks
Eaton's Semeslberger sells 17,000 ordinary shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRS

Carpenter Technology

$55.59

0.45 (0.82%)

15:51
09/16/19
09/16
15:51
09/16/19
15:51
Hot Stocks
Carpenter Technology director Steven Karol sells $275K in company shares »

Carpenter Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,806.42

-31.07 (-1.69%)

15:51
09/16/19
09/16
15:51
09/16/19
15:51
Hot Stocks
Amazon says WSJ search results story is wrong »

In response to a Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MUR

Murphy Oil

$25.21

4.62 (22.44%)

15:45
09/16/19
09/16
15:45
09/16/19
15:45
Options
Murphy Oil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRU

Prudential

$89.11

-0.74 (-0.82%)

15:38
09/16/19
09/16
15:38
09/16/19
15:38
Hot Stocks
Prudential subsidiaries charged with failing to disclose conflicts of interest »

The SEC charged two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 10

    Oct

  • 05

    Nov

GILD

Gilead

$65.80

-0.73 (-1.10%)

, GSK

GlaxoSmithKline

$40.64

-0.24 (-0.59%)

15:36
09/16/19
09/16
15:36
09/16/19
15:36
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotechnology Analysts,…

GILD

Gilead

$65.80

-0.73 (-1.10%)

GSK

GlaxoSmithKline

$40.64

-0.24 (-0.59%)

MRK

Merck

$81.90

-0.71 (-0.86%)

MYL

Mylan

$21.84

0.16 (0.74%)

TEVA

Teva

$8.09

0.15 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 18

    Sep

  • 18

    Sep

  • 20

    Sep

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 29

    Oct

AXSM

Axsome Therapeutics

$29.33

2.48 (9.24%)

15:30
09/16/19
09/16
15:30
09/16/19
15:30
Options
Ratio Put spread buyer in Axsome therapeutics as shares touch all-time highs »

Ratio Put spread buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPE

Callon Petroleum

$5.29

0.775 (17.18%)

15:25
09/16/19
09/16
15:25
09/16/19
15:25
Options
Callon Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 02

    Oct

ARAY

Accuray

$3.08

0.05 (1.65%)

15:25
09/16/19
09/16
15:25
09/16/19
15:25
Recommendations
Accuray analyst commentary  »

Accuray to host investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

SPY

SPDR S&P 500 ETF Trust

$300.17

-0.9 (-0.30%)

, SPX

S&P 500

$0.00

(0.00%)

15:21
09/16/19
09/16
15:21
09/16/19
15:21
Periodicals
Manhattan D.A. issues subpoena for Trump's tax records, NY Times reports »

Late last month,…

SPY

SPDR S&P 500 ETF Trust

$300.17

-0.9 (-0.30%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNOW

NOW Inc.

$12.79

0.51 (4.15%)

15:18
09/16/19
09/16
15:18
09/16/19
15:18
Conference/Events
NOW Inc. management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 06

    Nov

  • 13

    Nov

YETI

Yeti

$29.16

-0.9 (-2.99%)

15:17
09/16/19
09/16
15:17
09/16/19
15:17
Conference/Events
Yeti management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/16/19
09/16
15:17
09/16/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGR

Avangrid

$50.84

0.05 (0.10%)

15:16
09/16/19
09/16
15:16
09/16/19
15:16
Conference/Events
Avangrid management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 02

    Oct

  • 10

    Nov

  • 10

    Nov

ALDR

Alder Biopharmaceuticals

$18.44

8.385 (83.43%)

15:16
09/16/19
09/16
15:16
09/16/19
15:16
Downgrade
Alder Biopharmaceuticals rating change  »

Alder Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 21

    Feb

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/16/19
09/16
15:16
09/16/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRX

Brixmor

$19.64

0.065 (0.33%)

15:14
09/16/19
09/16
15:14
09/16/19
15:14
Conference/Events
Brixmor management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.